Key considerations based on pharmacokinetic/pharmacodynamic in the design of antibody-drug conjugates

BackgroundAntibody-drug conjugate (ADC) is an anticancer drug that links toxins to specifically targeted antibodies via linkers, offering the advantages of high target specificity and high cytotoxicity. However, complexity of its structural composition poses a greater difficulty for drug design stud...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Yangyang Gao, Yuwei Xia, Yixin Chen, Shiqi Zhou, Yingying Fang, Jieru Yu, Leyin Zhang, Leitao Sun
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2025-01-01
Seri Bilgileri:Frontiers in Oncology
Konular:
Online Erişim:https://www.frontiersin.org/articles/10.3389/fonc.2024.1459368/full